EBSA20 Conference programme

Wednesday, 26 April 2017

17:30 - 19:00 Registration, welcome reception and opening exhibition



Thursday, 27 April 2017

08:00 Registration
08:45 Opening
Gijsbert van Willigen, EBSA President 2016
09:00 Welcome

Virginia Gálvez Perez, Directora de Departamento de Higiene, CNNT- INSHT, Spain

Iñaki Echeverria Machado. Spanish Biosafety Association (AEBioS). President

09:15 Biosafety Issues of Integrative Viral Gene Therapy
Dr. Guillermo Güenechea, Head of Gene Therapy Safety Unit, Hematopoietic Innovative Therapies, CIEMAT/CIBERER/IIS-FJD, Spain
10:00 Coffee break + exhibition

Parallel session 1 Biosafety in hospital settings

Parallel session 2 Biosafety and vector organisms


Clinical care of Hemorrhagic fevers in Madrid: our two years learning curve

Dr. Marta Mora-Rillo, Hospital Universitario La Paz-Carlos III

Working with arthropods at a BSL3: to be bitten or not to be bitten

Xavier Abad, IRTA-CReSA, Centre de Recerca en Sanitat Animal - Animal Health Research Center (Cataluña Autonomous Community)


High Isolation Level Unit and Biosafety at the Defence Central Hospital "Gómez Ulla"

Dr. Patricia Obregon, Head of Biosafety HILU, High Level Isolation Unit and Biosafety at the Defense Central Hospital “Gómez Ulla”, Spain

Biosafety recommendations for One-health parasites

Dr. Muhammad Imran RASHID, Assistant Professor; Department of Parasitology, University of Veterinary and Animal Sciences, Lahore, Pakistan
Mycobacterium chimaera infections linked to  cardiac surgery  - what are the risks and how to do you prevent exposure?

Jimmy Walker, Scientific Lead for Water and Decontamination, Public Health England

Horizontal gene transfer of antibiotic resistance genes to native waste water flora
Dr. Claudia Bagutti, Gesundheitsdepartement des Kantons Basel-Stadt, Switzerland

12:00 Lunch + exhibition

Poster Presentations


Photo contest

AAF International presentation

Understanding the Math of Thermal Treatment - a Practical Discussion
PriBio presentation

ACTINI SAS presentation                 

Grupo Albian
14:00 Chris Collins Lecture
WHO GAP III roadmap to compliance for poliovirus-essential facilities
Toon De Kesel, Biorisk Expert, Febris, Belgium
15:00 Coffee break + exhibition

Session 3 Ethics of biosafety


Quality vs Biorisk management: and the winner is…?

Franca Rizzo, Anses-Nancy Laboratory for Rabies and Wildlife, France


Assessment the efficiency of disinfectants used in decontamination activities in CLEVB

Nermin Hodhod, Central Laboratory for Evaluation of Veterinary Biologics (CLEVB), Egypt

16:30 The Many Components of Strengthening National Biorisk Systems Around the Globe
Natalie DeGraaf, U.S. Centers for Disease Control - Division of Select Agents and Toxins, United States of America

Annual General Meeting of EBSA

19:30 Conference Dinner



Friday, 28 April 2017

08:30 Coffee

Session 4 Applied biosafety


Infection prevention in the laboratories and in hospitals

Jaap J. Maas, Center for Occupational Diseases, The Netherlands


Searching suitable FFP - masks

Kathleen Anthonis, Institute of Tropical Medicine, Belgium


Developing Capacity of a National Biosafety Organization through Collaborative Engagement with a donor: Pakistan as a case study

Zeba Rasmussen, Fogarty International Center National Institutes of Health, United States of America

10:30 Coffee break + exhibition

Session 5 Break-out discussion groups


Break-out 1: Discussion - Setting up a regional organization

Delphine Beeckman, President, BBP, Belgium
Jörge Perez, Council member, AEBioS, Spain


Break-out 2: Discussion - DURC / GOF research – self regulation vs. govt

Dr. Rik Bleijs, Biosecurity Office, National Institute for Public Health and the Environment, The Netherlands
Katja Nyholm Olsen, Head of Laboratory Division, Centre for Biosecurity and Biopreparedness, Denmark


Break-out 3: Discussion - Coping with the diversity in risk classification

Dr. Patrick Rüdelsheim, General Partner, Perseus, Belgium
Aline Baldo, Biosafety expert , Scientific Institute of Public Health, Belgium


Break-out 4: Discussion - When health issues affect the ability to work with biological agents

Arie Voordouw, Academic Medical Centre University of Amsterdam, The Netherlands
Jaap J. Maas, Center for Occupational Diseases, The Netherlands


Break-out 5: Discussion - The biosafety professional – which route to competence recognition? What have other groups done and what can we learn from them? Come and discuss your future

Heather Sheeley, EBSA-ETWG
Marina Claros, EBSA-ETWG


Break-out 6: Toolbox - Maintenance cost of facilities and equipment

Anton de Paiva, Imperial College London, United Kingdom


Break-out 7: Toolbox - Decontamination of prions – provision of safe surgical instruments

Miguel Calero, Chief of Spongiform Encephalopathies Unit, Health Institute Carlos III - CIBERNED, Spain
Dr. Jimmy Walker, Scientific Leader for Water and Decontamination,Biosafety, Air and Water Microbiology Group, Public Health England

12:30 Lunch + exhibition

Session 6 Applied biosafety


Technical mishaps & bioafety

Niel Godden, United Kingdom


CVRL Backweston: A Re-Established Laboratory Envelope

Gordon Handziuk, Vice President, Engineer, WSP Parsons Brinckerhoff, United States


An improved approach for the classification of micro-organisms into risk groups: example of HP avian influenza A H5N1 viruses
Aline Baldo, Biosafety expert , Scientific Institute of Public Health, Belgium

Closing session


Investigating Laboratory incidents

Ir. Margot Spreuwenberg, ILT, The Netherlands

15:30 Closing - Gabriel O'Riordain, EBSA President 2017-19
16:00 Coffee break


  Non-member prices (incl. local VAT)M Member prices (incl. local VAT)
Conference fee 588 EURO 468 EURO
Conference dinner 60 EURO 60 EURO


Exhibitors and sponsors (exhibition from 26 April - 28 April)

Confirmed Exhibitors - Sponsors